| 注册
首页|期刊导航|山东医药|纤溶酶原激活物抑制剂1在血管衰老中的作用机制研究进展

纤溶酶原激活物抑制剂1在血管衰老中的作用机制研究进展

王大君 王霞 张恬 刘炬

山东医药2025,Vol.65Issue(9):131-134,4.
山东医药2025,Vol.65Issue(9):131-134,4.DOI:10.3969/j.issn.1002-266X.2025.09.028

纤溶酶原激活物抑制剂1在血管衰老中的作用机制研究进展

Research progress on role of plasminogen activator inhibitor-1 in vascular aging

王大君 1王霞 1张恬 1刘炬1

作者信息

  • 1. 山东第一医科大学第一附属医院医学研究中心,山东 济南 250014
  • 折叠

摘要

Abstract

Vascular aging refers to the process of a series of structural and functional changes in blood vessels with ag-ing.Endothelial dysfunction is an early manifestation of vascular aging.Plasminogen activator inhibitor 1(PAI-1)has been identified as a senescence-associated secretory phenotype and a marker of endothelial cell senescence.PAI-1 can par-ticipate in vascular aging by promoting vascular endothelial cell senescence,perivascular fibrosis,thrombosis and vascular inflammation.Systematic study on the mechanism of PAI-1 in vascular aging and its related vascular diseases can provide new ideas for the prevention and treatment of vascular aging-related diseases.

关键词

血管衰老/纤溶酶原激活物抑制剂1/血管周围纤维化/血栓形成/炎症

Key words

vascular aging/plasminogen activator inhibitor 1/perivascular fibrosis/thrombosis/inflammation

分类

医药卫生

引用本文复制引用

王大君,王霞,张恬,刘炬..纤溶酶原激活物抑制剂1在血管衰老中的作用机制研究进展[J].山东医药,2025,65(9):131-134,4.

基金项目

山东省自然科学基金青年项目(ZR2022QH341). (ZR2022QH341)

山东医药

1002-266X

访问量0
|
下载量0
段落导航相关论文